Swift Biosciences

Swift Biosciences is a company that develops library preparation kits with a focus on the genomics, translational, and clinical research sector. Its products are designed to help analyze DNA and RNA samples for applications, including liquid biopsy, methylation sequencing, whole genome, exome, and transcriptome sequencing as well as chromatin studies. The company provides research tools that can be applied in agrigenomics, biotechnology, metagenomics, and the pharmaceutical industry.

Employee Rating

4.1
TypeSubsidiary
Parent CompanyIntegrated DNA Technologies
HQAnn Arbor, MI, US
Founded2014
Cybersecurity ratingAMore
Swift Biosciences was founded in 2014 and is headquartered in Ann Arbor, MI, US
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Swift Biosciences

Vladimir Makarov

Vladimir Makarov

Chief Scientific Officer
Christine Haakenson

Christine Haakenson

Senior Vice President of Operations
Laurie Kurihara

Laurie Kurihara

Vice President Product Development
Camille Cappello

Camille Cappello

Vice President, Global Marketing
Kellie Feck

Kellie Feck

Vice President of Sales, North America
Jack Ball

Jack Ball

Director
Show more

Swift Biosciences Office Locations

Swift Biosciences has an office in Ann Arbor
Ann Arbor, MI, US (HQ)
674 S Wagner Rd #100
Show all (1)

Swift Biosciences Financials and Metrics

Summary Metrics

Founding Date

2014

Total Funding

$31.2 m

Investors

In total, Swift Biosciences had raised $31.2 m. Swift Biosciences is a subsidiary of Integrated DNA Technologies

Swift Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

100/100

SecurityScorecard logo

Swift Biosciences Online and Social Media Presence

Embed Graph

Swift Biosciences Blogs

Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City

Ralf Duerr, Dacia Dimartino, Christian Marier, Paul Zappile, Guiqing Wang, Jennifer Lighter, Brian Elbel, Andrea B. Troxel, and Adriana Heguy The novel beta-coronavirus SARS-CoV-2 arose as a new human pathogen at the end of 2019 and rapidly spread to every corner of the globe, causing a pandemic of …

Examining age-dependent DNA methylation patterns and gene expression in the male and female mouse hippocampus

Carlene A. Chinn, Honglei Ren, Julien L.P. Morival, Qing Nie, Marcelo A. Wood, Timothy L. Downing DNA methylation is a well-characterized epigenetic modification involved in numerous molecular and cellular functions. Methylation patterns have also been associated with aging mechanisms. However, how …

Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX

Fleur van der Sijde , Zakia Azmani, Marc G. Besselink, Bert A. Bonsing, Jan Willem B. de Groot, Bas Groot Koerkamp, Brigitte C. M. Haberkorn, Marjolein Y. V. Homs, Wilfred F. J. van IJcken , Quisette P. Janssen, Martijn P. Lolkema, Saskia A. C. Luelmo , Leonie J. M. Mekenkamp, Dana A. [...]

DNA methylation analysis reveals epimutation hotspots in patients with dilated cardiomyopathy-associated laminopathies

Julien L. P. Morival, Halida P. Widyastuti, Cecilia H. H. Nguyen , Michael V. Zaragoza and Timothy L. Downingen L. P. Morival, Halida P. Widyastuti, Cecilia H. H. Nguyen , Michael V. Zaragoza and Timothy L. Downing Mutations in LMNA, encoding lamin A/C, lead to a variety of diseases known as laminop…

Probing the signaling requirements for naive human pluripotency by high-throughput chemical screening

Shafqat A. Khan, Kyoung-mi Park, Laura A. Fischer, Chen Dong, Tenzin Lungjangwa, Marta Jimenez, Dominick Casalena, Brian Chew, Sabine Dietmann, Douglas S. Auld, Rudolf Jaenisch, and Thorold W. Theunissen Naive human embryonic stem cells (hESCs) have been isolated that more closely resemble the pre-i…

Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory

Andreas Lind, Regine Barlinn, Elisabeth Toverud Landaas, Lise Lima Andresen, Kirsti Jakobsen, Cathrine Fladeby, Mariann Nilsen, Pål Marius Bjørnstad, Arvind Y. M. Sundaram, Teodora Ribarska, Fredrik Müller, Gregor D. Gilfillan , Mona Holberg-Petersen The discovery of a new SARS-CoV-2 variant (lineag…
Show more

Swift Biosciences Frequently Asked Questions

  • When was Swift Biosciences founded?

    Swift Biosciences was founded in 2014.

  • Who are Swift Biosciences key executives?

    Swift Biosciences's key executives are Vladimir Makarov, Christine Haakenson and Laurie Kurihara.

  • How many employees does Swift Biosciences have?

    Swift Biosciences has 24 employees.

  • Who are Swift Biosciences competitors?

    Competitors of Swift Biosciences include RPRD Diagnostics, Diagnomics and Affymetrix.

  • Where is Swift Biosciences headquarters?

    Swift Biosciences headquarters is located at 674 S Wagner Rd #100, Ann Arbor.

  • Where are Swift Biosciences offices?

    Swift Biosciences has an office in Ann Arbor.

  • How many offices does Swift Biosciences have?

    Swift Biosciences has 1 office.